Pulse Newsletter
Browse page 22 of our Pulse Newsletter articles in the Thrivous Views blog at Thrivous. They're listed below. If you prefer, you can also browse all articles in Thrivous Views. Or search for articles and other content on the Thrivous website.
-
Removing Senescent Cells Reduces Harm of Aging
Aging starts in our cells, and those aging cells can hasten cellular senescence, leading to tissue dysfunction and related health ...
-
3D Molecular Engineering for Cancer Immunotherapy
A new molecular engineering technology dubbed PSI, developed by scientists at Scripps Research and Bristol-Myers Squibb (see below), acts like ...
-
AI for Drug Discovery from Scratch
An Artificial Intelligence (AI) system, dubbed ReLeaSE (see below), developed by University of North Carolina scientists, has demonstrated AI-based drug ...
-
Happy Thoughts May Boost Immunity to Cancer
Scientists working on ways to combat dangerous cancers are exploring a treatment path that may wind up being as simple ...
-
Gene Editing for Cell Therapy and Designer Babies
Scientists have found a way to efficiently and precisely remove genes from white blood cells of the immune system and ...
-
VR Is Useful and Fun, But Spend Time Outdoors Too
Scientists at the University of Bristol, with cloud computing and virtual reality (VR) experts, have designed a VR collaborative playground ...
-
No Fixed Limit to the Human Lifespan
New research results released last week don’t support the idea that humans have a fixed expiration date — no hardwired ...
-
Supercomputing for Personalized Cancer Treatment
Working with a new supercomputing platform called OncoTreat (see below), scientists at Columbia University and biotech spin-off DarwinHealth are able ...
-
CRISPR Safety Under the Microscope
CRISPR gene editing (see Pulse 22) is rightly hailed as a potential game-changer in future medicine, but recent news released ...
-
New Cancer Immunotherapy Is Spectacular
Researchers at the US National Cancer Institute have developed a new, very promising approach to cancer immunotherapy (see below). According ...
